Combinations comprising a protein kinase inhibitor being a pyrimidylaminobenzamide compound and a hsp90 inhibitor such as 17-aag

and a method for treating or preventing a proliferative disease using such a combination.

b) an HSP90 inhibitor,
a) a pyrimidylaminobenzamide compound; and



The invention provides a pharmaceutical combination comprising:...

More information Learn more Click here